UK medicines proposal threatens medical device manufacturers with easier prosecution
This article was originally published in Clinica
Executive Summary
UK Medical device and diagnostic manufacturers could face prosecution if they wrongly classify products the UK Medicines Control Agency (MCA) deems to be medicines. A new threat to the industry is looming in the form of a proposed change to UK legislation which would make the MCA the sole arbiter over whether a product is classified a medicine, bypassing the courts.